PwC India introduces a comprehensive GenAI framework to guide healthcare providers on how to adopt relevant business relevant use cases. GenAI is revolutionising Indian healthcare, delivering better patient care, diagnostic accuracy and operational efficiency. The Indian GenAI market is expected to grow at a CAGR
Dr. Bhaskar Viswanathan, HoD, Department of Radiation Oncology, Amrita Hospital, Faridabad, will be collaborating with IIT Hyderabad, Eranki Labs, and Amrita Centre for Advanced Robotics Dr. Bhaskar Viswanathan, HoD, Department of Radiation Oncology, Amrita Hospital, Faridabad, has been recently selected for a research grant, meant to
Mr. Lovekesh Phasu, Group COO, Sakra World Hospital, Bengaluru While the government's laudable efforts, such as cervical cancer vaccination and maternal healthcare schemes, tackle vital health concerns, there remains room for improvement. Greater emphasis on budgetary allocations for healthcare infrastructure, telemedicine expansion, medical research funding, could
In an effort to reduce complications and average HbA1c levels for people with diabetes, BeatO, a comprehensive digital platform for controlling and managing diabetes studied the impact of its proprietary Diabetes Care Program. This program has been subjected to clinical studies and its results were
Mr. Akshay Oleti, Business Head, Fortis Hospitals, Bengaluru The healthcare sector in India is undergoing a transformative shift with the rapid adoption of technology. From electronic health records (EHRs) to telemedicine and artificial intelligence (AI), technology is revolutionizing healthcare access, delivery, and patient outcomes. Technology adoption
KRIVIDA TRIVUS developed by Chennai-based KRIYA Medical technologies has received approval from ICMR (Indian Council of Medical Research). The RT-qPCR kit can detect the presence or absence of three pathogens - Influenza (H1N1, H3N2,Yamagata and Victoria sublineages), SARS CoV2, and Respiratory Syncytial Virus (RSV). The
Patients treated with Proton Beam Therapy share their successful experience With the mission to provide the most comprehensive and advanced cancer care in India, Apollo Proton Cancer Centre (APCC), the first and only proton therapy centre in South Asia and the Middle East, has successfully
RNA extraction free kit to deliver results in just 45 Min. Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of ‘RT-Direct’ multiplex COVID-19 RT PCR Test kit in India, in partnership with Genes2Me Pvt. Ltd. With this, Cipla
Eqova Healthcare Pvt. Ltd. (Eqova) announced its transaction with Max Healthcare Institute Ltd (MHIL) in order to aid development and provide high end medical services to the 400 bed hospital to be built on a 2.1 acres of land parcel in Patparganj, Delhi; owned by
